DV
Dividend Vision

INBP Stock — Integrated Biopharma Inc

Integrated Biopharma Inc (INBP)

Updated October 15, 2026.

INBP is a Stock. Total return is -97.8% over the past 30 years, 1837.3 points behind SPY at 1739.5%.

Integrated BioPharma manufactures and distributes vitamins, nutritional supplements, and herbal products through contract manufacturing for health-care providers and multilevel marketers, along with warehousing, fulfillment, and raw materials distribution services, primarily serving the U.S. and Luxembourg markets. The company does not currently distribute to shareholders. This business appeals primarily to value or growth-oriented investors rather than those seeking regular dividend income.

INBP dividend yield and income

Price as of 2026-10-15.

The ex-dividend date is 08/19/2008.

INBP performance versus SPY

Price and return data through 2026-10-15.

Total return is -97.8% over the past 30 years, 1837.3 points behind SPY at 1739.5%. Over the past year its total return — price change plus distributions reinvested — is -43.5%. Its deepest 1-year drawdown was 60.5%.

WindowTotal returnCAGR
1M-2.8%—
3M9.4%—
6M-37.5%—
YTD-51.4%—
1Y-43.5%—
2Y CAGR—-16.30%
3Y CAGR—-13.40%
5Y CAGR—-30.60%
10Y CAGR—1.10%
Since inception (30 years)-97.8%-12.00%

INBP key facts

Asset type
Stock
Asset class
Equity
Inception date
10/30/1996
Distribution frequency
None
Last close
$0.17 (as of 2026-10-15)
Market cap
$5,435,432
Average volume
300.0
Ex-dividend date
08/19/2008
Beta
0.404
Payout ratio
0.0%
EPS
$-0.09

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

INBP risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 60.5%.

Who may consider INBP — and who may not

It is a weaker fit for investors who need monthly cash flow (INBP does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on INBP

Tagged: Healthcare, Dividend.

Frequently asked questions

Does INBP pay monthly?

No. INBP does not currently distribute.

When does INBP pay a dividend?

INBP does not currently distribute. The ex-dividend date is 08/19/2008.

How has INBP performed?

Total return is -97.8% over the past 30 years, 1837.3 points behind SPY at 1739.5%. Over the past year its total return — price change plus distributions reinvested — is -43.5%. Its deepest 1-year drawdown was 60.5%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.